Skip to main content
Retour
Watch Compare

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Qualité des données : 83%
PACB
Nasdaq Manufacturing Measuring & Analyzing Instruments
1,34 €
▼ 0,01 € (-0,74%)
Cap. Boursière: 412,23 M
Prix
1,37 €
Cap. Boursière
412,23 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -113,92 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-1119,86%
En dessous de la moyenne du secteur (-53,34%)
ROIC-58,12%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio6,24
Interest Coverage-79,65

Valorisation

PE (TTM)
-0,75
Au-dessus de la moyenne du secteur (-1,47)
P/B Ratio11,42
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,8 -1,5
P/B 11,4 1,6
ROE % -1119,9 -53,3
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

6 analystes
Hold
Actuel
1,34 €
+92.8%
Objectif
2,58 €
1,50 €
3,00 €
3,00 €
Prévisions
P/E Prévisionnel -3,25
BPA Prévisionnel -0,41 €
CA Est. 196,59 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -0,41 €
-0,47 € – -0,24 €
 196,59 M 7
FY2026 -0,51 €
-0,53 € – -0,47 €
 174,38 M 7

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,13 € -0,12 € +10,8%
Q32025 -0,14 € -0,12 € +15,1%
Q22025 -0,17 € -0,13 € +21,5%
Q12025 -0,19 € -0,15 € +20,5%

ETFs Holding This Stock

ARKG ARKG
1,95% weight
NXTE logo NXTE AXS Green Alpha ETF
0,45% weight
ARKK ARKK
0,41% weight
WDNA WDNA
0,31% weight
MEDX logo MEDX Horizon Kinetics Medical ETF
0,08% weight
GINN logo GINN Goldman Sachs Innovate Equity ETF
0,08% weight
WSMVX WSMVX
0,02% weight
DTSVX DTSVX
0,02% weight
VVICX VVICX
0,02% weight
IRSIX IRSIX
0,02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -546,38 M
ROE -1119,86% ROA -67,10%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -113,92 M
ROIC -58,12% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6,24
Interest Coverage -79,65 Asset Turnover N/A
Working Capital 331,03 M Tangible Book Value -297,81 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,75 Forward P/E N/A
P/B Ratio 11,42 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -27,64%
Market Cap 412,23 M Enterprise Value 355,76 M
Per Share
EPS (Diluted TTM) -1,82 Revenue / Share N/A
FCF / Share -0,38 OCF / Share -0,37
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 20,85%
SBC-Adj. FCF -164,26 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -546,38 M -309,85 M -306,74 M -314,25 M -181,22 M
EPS (Diluted) -1,82 -1,59 -1,21 -1,40 -0,89
Gross Profit 45,78 M 37,28 M 52,78 M 49,04 M 58,86 M
Operating Income -553,86 M -474,31 M -334,47 M -307,20 M -210,44 M
EBITDA — — — — —
R&D Expenses 97,31 M 134,92 M 187,17 M 193,00 M 112,90 M
SG&A Expenses 141,49 M 175,02 M 169,82 M 160,85 M 124,12 M
D&A — — — — —
Interest Expense 6,95 M 13,41 M 14,34 M 14,69 M 12,53 M
Income Tax 318 000,0 316 000,0 -11,42 M -93,65 M -93,65 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 784,08 M 1,26 B 1,75 B 1,77 B 2,01 B
Total Liabilities 778,73 M 753,85 M 1,04 B 1,20 B 1,22 B
Shareholders' Equity 5,35 M 506,59 M 701,30 M 562,90 M 790,99 M
Total Debt — 0,0 490 000,0 898,53 M 896,07 M
Cash & Equivalents 63,71 M 55,37 M 179,91 M 325,09 M 460,73 M
Current Assets 375,05 M 495,68 M 742,05 M 852,07 M 1,10 B
Current Liabilities 72,83 M 66,30 M 95,03 M 263,34 M 71,71 M